These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeting G with TAL effectors: a comparison of activities of TALENs constructed with NN and NK repeat variable di-residues. Christian ML; Demorest ZL; Starker CG; Osborn MJ; Nyquist MD; Zhang Y; Carlson DF; Bradley P; Bogdanove AJ; Voytas DF PLoS One; 2012; 7(9):e45383. PubMed ID: 23028976 [TBL] [Abstract][Full Text] [Related]
4. SAPTA: a new design tool for improving TALE nuclease activity. Lin Y; Fine EJ; Zheng Z; Antico CJ; Voit RA; Porteus MH; Cradick TJ; Bao G Nucleic Acids Res; 2014 Apr; 42(6):e47. PubMed ID: 24442582 [TBL] [Abstract][Full Text] [Related]
5. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Guilinger JP; Pattanayak V; Reyon D; Tsai SQ; Sander JD; Joung JK; Liu DR Nat Methods; 2014 Apr; 11(4):429-35. PubMed ID: 24531420 [TBL] [Abstract][Full Text] [Related]
6. Directed evolution of the TALE N-terminal domain for recognition of all 5' bases. Lamb BM; Mercer AC; Barbas CF Nucleic Acids Res; 2013 Nov; 41(21):9779-85. PubMed ID: 23980031 [TBL] [Abstract][Full Text] [Related]
7. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459 [TBL] [Abstract][Full Text] [Related]
8. Context and number of noncanonical repeat variable diresidues impede the design of TALE proteins with improved DNA targeting. Anderson JT; Rogers JM; Barrera LA; Bulyk ML Protein Sci; 2020 Feb; 29(2):606-616. PubMed ID: 31833142 [TBL] [Abstract][Full Text] [Related]
9. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Hubbard BP; Badran AH; Zuris JA; Guilinger JP; Davis KM; Chen L; Tsai SQ; Sander JD; Joung JK; Liu DR Nat Methods; 2015 Oct; 12(10):939-42. PubMed ID: 26258293 [TBL] [Abstract][Full Text] [Related]
10. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Mussolino C; Alzubi J; Fine EJ; Morbitzer R; Cradick TJ; Lahaye T; Bao G; Cathomen T Nucleic Acids Res; 2014 Jun; 42(10):6762-73. PubMed ID: 24792154 [TBL] [Abstract][Full Text] [Related]
11. Designing and testing the activities of TAL effector nucleases. Lin Y; Cradick TJ; Bao G Methods Mol Biol; 2014; 1114():203-19. PubMed ID: 24557905 [TBL] [Abstract][Full Text] [Related]
13. Indirect DNA Sequence Recognition and Its Impact on Nuclease Cleavage Activity. Lambert AR; Hallinan JP; Shen BW; Chik JK; Bolduc JM; Kulshina N; Robins LI; Kaiser BK; Jarjour J; Havens K; Scharenberg AM; Stoddard BL Structure; 2016 Jun; 24(6):862-73. PubMed ID: 27133026 [TBL] [Abstract][Full Text] [Related]
14. Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Sun N; Zhao H Biotechnol Bioeng; 2013 Jul; 110(7):1811-21. PubMed ID: 23508559 [TBL] [Abstract][Full Text] [Related]
15. Exploring the transcription activator-like effectors scaffold versatility to expand the toolbox of designer nucleases. Juillerat A; Beurdeley M; Valton J; Thomas S; Dubois G; Zaslavskiy M; Mikolajczak J; Bietz F; Silva GH; Duclert A; Daboussi F; Duchateau P BMC Mol Biol; 2014 Jul; 15():13. PubMed ID: 24997498 [TBL] [Abstract][Full Text] [Related]
16. Compact designer TALENs for efficient genome engineering. Beurdeley M; Bietz F; Li J; Thomas S; Stoddard T; Juillerat A; Zhang F; Voytas DF; Duchateau P; Silva GH Nat Commun; 2013; 4():1762. PubMed ID: 23612303 [TBL] [Abstract][Full Text] [Related]
17. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Cermak T; Doyle EL; Christian M; Wang L; Zhang Y; Schmidt C; Baller JA; Somia NV; Bogdanove AJ; Voytas DF Nucleic Acids Res; 2011 Jul; 39(12):e82. PubMed ID: 21493687 [TBL] [Abstract][Full Text] [Related]